Role of sphingolipids in murine radiation‐induced lung injury: protection by sphingosine 1‐phosphate analogs

• Published in: The FASEB journal 2011-10, Vol.25 (10), p.3388-3400
• Main Authors: Mathew, Biji, Jacobson, Jeffrey R., Berdyshev, Evgeny, Huang, Yong, Sun, Xiaoguang, Zhao, Yutong, Gerhold, Lynnette M., Siegler, Jessica, Evenoski, Carrie, Wang, Ting, Zhou, Tong, Zaidi, Rafe, Moreno‐Vinasco, Liliana, Bittman, Robert, Chen, Chin Tu, LaRiviere, Patrick J., Sammani, Saad, Lussier, Yves A., Dudek, Steven M., Natarajan, Viswanathan, Weichselbaum, Ralph R., Garcia, Joe G. N.
• Format: Article
• Language: English
• Subjects: Alveoli; Animals; Bronchoalveolar Lavage Fluid - chemistry; Ceramides - metabolism; Female; FTY720; fTysiponate; Gene Deletion; gene dysregulation; Gene Expression Regulation - physiology; Lung - radiation effects; Lysophospholipids - chemistry; Lysophospholipids - pharmacology; Mice; Mice, Inbred C57BL; Mice, Knockout; Radiation Injuries, Experimental; Receptors, Lysosphingolipid - genetics; Receptors, Lysosphingolipid - metabolism; Research Communications; S1P receptors; Sphingolipids - metabolism; Sphingosine - analogs & derivatives; Sphingosine - chemistry; Sphingosine - pharmacology
• ISSN: 0892-6638; 1530-6860
• DOI: 10.1096/fj.11-183970

ABSTRACT Clinically significant radiation‐induced lung injury (RILI) is a common toxicity in patients administered thoracic radiotherapy. Although the molecular etiology is poorly understood, we previously characterized a murine model of RILI in which alterations in lung barrier integrity surfaced as a potentially important pathobiological event and genome‐wide lung gene mRNA levels identified dysregulation of sphingolipid metabolic pathway genes. We hypothesized that sphingolipid signaling components serve as modulators and novel therapeutic targets of RILI. Sphingolipid involvement in murine RILI was confirmed by radiation‐induced increases in lung expression of sphingosine kinase (SphK) isoforms 1 and 2 and increases in the ratio of ceramide to sphingosine 1‐phosphate (S1P) and dihydro‐S1P (DHS1P) levels in plasma, bronchoalveolar lavage fluid, and lung tissue. Mice with a targeted deletion of SphK1 (SphK1–/–) or with reduced expression of S1P receptors (S1PR1+/–, S1PR2–/–, and S1PR3–/–) exhibited marked RILI susceptibility. Finally, studies of 3 potent vascular barrier‐protective S1P analogs, FTY720, (S)‐FTY720‐phosphonate (fTyS), and SEW‐2871, identified significant RILI attenuation and radiation‐induced gene dysregulation by the phosphonate analog, fTyS (0.1 and 1 mg/kg i.p., 2×/wk) and to a lesser degree by SEW‐2871 (1 mg/kg i.p., 2×/wk), compared with those in controls. These results support the targeting of S1P signaling as a novel therapeutic strategy in RILI.—Mathew, B., Jacobson, J. R., Berdyshev, E., Huang, Y., Sun, X., Zhao, Y., Gerhold, L. M., Siegler, J., Evenoski, C., Wang, T., Zhou, T., Zaidi, R., Moreno‐Vinasco, L., Bittman, R., Chen, C. T., LaRiviere, P. J., Sammani, S., Lussier, Y. A., Dudek, S. M., Natarajan, V., Weichselbaum, R. R., Garcia, J. G. N. Role of sphingolipids in murine radiation‐induced lung injury: protection by sphingosine 1‐phosphate analogs. FASEB J. 25, 3388–3400 (2011). www.fasebj.org